MAPT and Alzheimer disease: Decreased PP2A activity has been evidenced in the frontal and temporal cortices of AD patients (Sontag et al., 2004), which promotes tau hyperphosphorylation, and subsequent NFTs formation and synaptic degeneration (Shentu et al., 2018; Sun et al., 2012).